InvestorsHub Logo
Followers 22
Posts 1379
Boards Moderated 0
Alias Born 03/31/2017

Re: None

Thursday, 01/21/2021 5:57:09 PM

Thursday, January 21, 2021 5:57:09 PM

Post# of 403568
TIAB, You infer that because of SHARE PRICE being low ... Brilacidin will fail?

"The share price tells you what the world thinks about the chances of B success- not good."

Go TELL THAT TO THE FDA!

FDA just GRANTED to IPIX for BRILACIDIN:

1. Investigational New Drug approval

Investigational New Drug
The United States Food and Drug Administration's Investigational New Drug program is the means by which a pharmaceutical company obtains permission to start human clinical trials and to ship an experimental drug across state lines before a marketing application for the drug has been approved.

2. Fast Track Designation ...

FDA
Fast track is a designation by the United States Food and Drug Administration of an investigational drug for expedited review to facilitate development of drugs which treat a serious or life-threatening condition and fill an unmet medical need. Fast Track designation must be requested by the drug company.

OF COURSE... FDA grants these designations to Company's who's PROSPECTIVE DRUG CANDIDATES are DOOMED TO FAIL!

What a joke!

Your judgment appears to suffering from..."Eyes (and mind) wide Shut!"

Innovation Pharmaceuticals’ Brilacidin for the Treatment of COVID-19 Receives FDA Fast Track Designation

FDA Grants IND Approval for Phase 2 Clinical Trial of Innovation Pharmaceuticals - Brilacidin for Treating
COVID-19

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News